A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors

PURPOSE: BMS-690514 is a novel oral tyrosine kinase inhibitor of ErbB and vascular endothelial growth factor receptor. This open-label phase I dose-escalation study (ClinicalTrials.gov Identifier: NCT00516451) aimed to assess the safety, preliminary efficacy, pharmacokinetics, and pharmacodynamics o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nokihara, Hiroshi, Yamamoto, Noboru, Yamada, Yasuhide, Yamada, Kazuhiko, Hirata, Taizo, Goto, Yasushi, Tanioka, Maki, Ikeda, Yoko, Tamura, Tomohide
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2012
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3456941/
https://ncbi.nlm.nih.gov/pubmed/22878519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-012-1932-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados